a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication
- Conditions
- Endoscopic Retrograde Cholangiopancreatography
- Registration Number
- NCT06277414
- Lead Sponsor
- The First Affiliated Hospital of University of South China
- Brief Summary
To develop effective preoperative and postoperative prediction models for postoperative complications of ERCP
- Detailed Description
To develop effective preoperative and postoperative prediction models for postoperative complications of ERCP based on machine learning
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
- Routine ERCP patients
- Unwillingness or inability to consent for the study
- Pregnant women or breastfeeding
- current acute pancreatitis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of Participants with Pancreatitis 1 month Typical abdominal pain, with the level of serum amylase increasing at least 3 times of the normal range within 24 hours after ERCP.
- Secondary Outcome Measures
Name Time Method Number of Participants with Cholangitis 1 month Temperature should be more than 38 celsius degree, chills, with right upper abdominal pain, blood routine showing the total amount of the White Blood Cell (WBC), and the amount of polymorphonuclear neutrophil(PMN) are above normal
Number of Acute PEC(post-ERCP-cholecystitis ) 1 month Number of Acute PEC(post-ERCP-cholecystitis )
Number of Participants with Perforation 1 month Typical abdominal pain,abdominal muscle tension, and there are also radiographic evidence suggesting
Number of Participants with bile duct stents 1 month If it is necessary to get the patients drainage, Number of Participants with stents or endoscopic nasobiliary drainage (ENBD) should be recorded
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The First Affiliated Hospital of University of South China
🇨🇳Hengyang, Hunan, China
The First Affiliated Hospital of University of South China🇨🇳Hengyang, Hunan, China